Most Cannabis Companies Underperformed Last Year, Need Funding to Survive

April 19, 2023 · Green Market Report

Several factors will combine to make 2023 a year of attrition.

Last year’s global cannabis market underperformed expectations, most companies will need funding to survive the coming year, and the industry outlook is “bleak.”

Those are some of the broad takeaways from a new report released this week by Ernst & Young Global Limited, an international cannabis consultancy. The informal poll, titled the “EY Global Cannabis CEO Survey,” was conducted between December and January.

There were roughly 50 respondents, including 28% from Canada, 20% from the United States, and the rest from Europe, South America, Australia, and Israel.

Among the findings:

  • Roughly 58% of companies fell short of financial performances expected by their boards of directors.
  • 57% of companies said they’d need more funding to survive the next 12 months.
  • More than 13% used layoffs to reduce costs in 2022.
  • 55% are expecting a good number of their competitors to exit the cannabis industry in 2023.

“While the cannabis market is expected to sustain its growth (albeit at a decelerating rate), the consensus outlook for the industry in 2023 is bleak,” the report concluded. “The cannabis industry is poised to experience its version of the dot-com bubble burst of 2000.”

The report asserted that cannabis executives believe several factors will combine to make 2023 a year of attrition, including:

  • Inflation
  • The expensive cost of capital
  • Increasing competition
  • Price compression
  • Margin pressure

“The theme for the short-term is ‘survival of the fittest,’” the report quipped. “A significant number of cannabis companies are expected to either collapse or become insolvent.”

The report attempted to put a rosy spin on the outlook as well, and forecasted that despite the likely failure of many cannabis companies – particularly in North America – the “long-term outlook on the industry is positive.”

It noted that the cannabis market just in the United States alone is estimated to be worth $100 billion, of which only about $25 billion is so far being bought and sold legally.

“In the future, we believe greater acceptability with legalization and innovation should boost that number,” the report stated.

But the bottom line is that first there’s going to be pain. And probably lots of it.

“After years of fast growth, the industry is expected to face a reset,” the report predicted. (Full Story)

In category:Business
Next Post

Green Market Report Women’s Leadership Awards: Rachel Edwards

Rachel Edwards heads research and development for Statehouse Holdings. Best Cultivation: Rachel Edwards, Statehouse Holdings Statehouse Holdings (CSE: STHZ), a leading player in the California cannabis industry, has made great strides under the guidance of its research and development manager, Rachel…
Read
Previous Post

Skymint Chairman, CEO Out as Company Battles Through Receivership

The chairman and CEO of troubled Skymint is out as the company battles through court-ordered receivership. “We can confirm that Jeff Radway is no longer with Skymint,” the company said in an emailed statement Tuesday. “As we work through this…
Read
Random Post

Top Maryland Marijuana Regulator Explains How The State So Quickly Implemented Sales After Voters Approved Legalization

A top Maryland marijuana regulator says the state’s proactive approach to legalizing cannabis has allowed it to implement a system that effectively balances three key priorities: safety, access and equity. When the state’s legalization law took effect at the beginning…
Read
Random Post

Trulieve Challenges $143 Million in Taxes

U.S. giant Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) is seeking a $143 million tax refund from the government for payments made in 2019, 2020, and 2021. The company argues that based on specific legal interpretations related to section 280E, it shouldn’t have…
Read
Random Post

Israel’s medical cannabis patient growth slows as industry awaits major reform

The growth in Israel’s medical cannabis industry has slowed over the past several months, but experts say regulatory changes are afoot that could reinvigorate patient numbers if the country’s tumultuous political situation stabilizes. The number of authorized medical cannabis patients…
Read
Random Post

Donald Trump Calls Cannabis 'Popular' Among Voters Though Damaging, Still Thinks Dealers Should Get Death Penalty

Donald Trump told Newsmax’s “Greg Kelly Reports” in a recent interview that marijuana does “significant damage” although he recognized that legalizing cannabis is a “pretty popular thing” among voters. Greg Kelly, who seemed slightly irked about the aroma of cannabis in the…
Read